Evidence map›Paper›PMID 20700462›Full record

ArticlePloS one2010

Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease.

Aurelia Santoro, Valentina Balbi, Elisa Balducci, Chiara Pirazzini, Francesca Rosini, Francesca Tavano, Alessandro Achilli, Paola Siviero, Nadia Minicuci, Elena Bellavista and 17 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. The Association of Mitochondrial tRNANeuropsychiatric disease and treatment · 2025
    Article
  7. Precision mitochondrial medicine.Cambridge prisms. Precision medicine · 2023
    Review
  8. Article
  9. Review
  10. Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Article
  18. Review
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 2 countries.

Aurelia SantoroDepartment of Experimental Pathology, University of Bologna, Bologna, Italy. aurelia.santoro@unibo.it
Valentina Balbi
Elisa Balducci
Chiara Pirazzini
Francesca Rosini
Francesca Tavano
Alessandro Achilli
Paola Siviero
Nadia Minicuci
Elena Bellavista
Michele Mishto
Stefano Salvioli
Francesca Marchegiani
Maurizio Cardelli
Fabiola Olivieri
Benedetta Nacmias
Andrea Maria Chiamenti
Luisa Benussi
Roberta Ghidoni
Giuseppina Rose
Carlo Gabelli
Giuliano Binetti
Sandro Sorbi
Gaetano Crepaldi
Giuseppe Passarino
Antonio Torroni
Claudio Franceschi
University of Bologna · ITCentro San Giovanni di Dio Fatebenefratelli · ITNeuroscience Institute · ITIstituto Nazionale di Riposo e Cura per Anziani · ITUniversity of Calabria · ITUniversity of Florence · ITUniversity of Pavia · ITCharité - Universitätsmedizin Berlin · DEI.R.C.C.S. Oasi Maria SS · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlzheimer's Disease (AD) is the most common neurodegenerative disease and the leading cause of dementia among senile subjects. It has been proposed that AD can be caused by defects in mitochondrial oxidative phosphorylation. Given the fundamental contribution of the mitochondrial genome (mtDNA) for the respiratory chain, there have been a number of studies investigating the association between mtDNA inherited variants and multifactorial diseases, however no general consensus has been reached yet on the correlation between mtDNA haplogroups and AD. METHODOLOGY/PRINCIPAL

findingsWe applied for the first time a high resolution analysis (sequencing of displacement loop and restriction analysis of specific markers in the coding region of mtDNA) to investigate the possible association between mtDNA-inherited sequence variation and AD in 936 AD patients and 776 cognitively assessed normal controls from central and northern Italy. Among over 40 mtDNA sub-haplogroups analysed, we found that sub-haplogroup H5 is a risk factor for AD (OR=1.85, 95% CI:1.04-3.23) in particular for females (OR=2.19, 95% CI:1.06-4.51) and independently from the APOE genotype. Multivariate logistic regression revealed an interaction between H5 and age. When the whole sample is considered, the H5a subgroup of molecules, harboring the 4336 transition in the tRNAGln gene, already associated to AD in early studies, was about threefold more represented in AD patients than in controls (2.0% vs 0.8%; p=0.031), and it might account for the increased frequency of H5 in AD patients (4.2% vs 2.3%). The complete re-sequencing of the 56 mtDNAs belonging to H5 revealed that AD patients showed a trend towards a higher number (p=0.052) of sporadic mutations in tRNA and rRNA genes when compared with controls.

conclusionsOur results indicate that high resolution analysis of inherited mtDNA sequence variation can help in identifying both ancient polymorphisms defining sub-haplogroups and the accumulation of sporadic mutations associated with complex traits such as AD.

Indexed as

Genetic Predisposition to DiseaseAgedAlzheimer DiseaseCase-Control StudiesDNA, MitochondrialFemaleHaplotypesHumansMutationPhylogenyPolymorphism, GeneticDNA, Mitochondrial

Identifiers

PMID20700462
PMCPMC2917370
OpenAlexW2056852384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.